Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
about
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosisIncidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaA three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in childrenDiagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?Current status of HIV infection: a review for non-HIV-treating physiciansProspective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence settingHigh rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test resultsNovel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association studyRecent developments in treatment of latent tuberculosis infectionTreatment outcome of new culture positive pulmonary tuberculosis in NorwayTuberculosis control: challenges of an ancient and ongoing epidemicThe specialist physician's approach to rheumatoid arthritis in South AfricaRecent advances in the diagnosis and treatment of childhood tuberculosisChallenging issues in tuberculosis in solid organ transplantationDiagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor TherapyDiagnosis and treatment of latent infection with Mycobacterium tuberculosisCurrent trends and intricacies in the management of HIV-associated pulmonary tuberculosisControlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionEvaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populationsA comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumabCost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange programLongitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary TuberculosisFrequent detection of latent tuberculosis infection among aged underground hard coal miners in the absence of recent tuberculosis exposureLongevity loss among cured tuberculosis patients and the potential value of preventionRates of latent tuberculosis in health care staff in RussiaCompletion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinicA Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort StudyNovel M tuberculosis antigen-specific T-cells are early markers of infection and disease progressionGranuloma encapsulation is a key factor for containing tuberculosis infection in minipigsCOPD and the risk of tuberculosis--a population-based cohort studyEnzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.Cerebral hemorrhage due to tuberculosis meningitis: a rare case report and literature review.Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models.Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.The presence of a booster phenomenon among contacts of active pulmonary tuberculosis cases: a retrospective cohortU.S. medical resident familiarity with national tuberculosis guidelinesTreatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort studyHumoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis
P2860
Q21133739-95789994-C007-43B0-97D3-F747BB500A37Q21142696-007C8D22-55DF-4A36-8505-D816C5FC7A92Q21521430-04B7FEA7-F370-467C-B9C6-9E62A7CFAF23Q21562599-1A18D03A-A3D7-427A-9553-5DC5F7CBF999Q22241488-A4198AD7-E8A7-4132-B172-9B330AF1BAEDQ22242613-3494B5BC-6216-4E53-828F-686068E40258Q23916389-CA8CB27C-8537-477C-B9AB-5AA4FB344E00Q23917093-E93F3B20-BF76-42EB-A4C9-4C1C52AAFDE4Q24618920-D13C58F2-8690-4F10-BE76-94589CF16172Q24630473-28F1130C-C175-4477-927B-E96671DEDB7EQ24793528-D80788A0-FB53-482B-A9DA-ACF738126524Q26206908-08888AF2-280E-45DC-8472-B494EA7F2844Q26765122-66A4BE7C-F9D7-47B7-B9F8-F8BA24ABDD31Q26797426-BA5FCBEB-F001-4A2C-85E5-5F065D51E64DQ26998877-47C772BC-F77C-4E42-92F0-4AE73D2A4668Q27005716-ADDB3704-C7DF-4E79-BC13-5CBE344F3F1EQ27021614-88CF8FC3-FA8B-4F01-AE91-F0ACC09CEA98Q28069032-5670AB92-FC8A-41C2-9CCA-B53A7F11DC39Q28087385-3920D4B2-5D44-42CD-8D1C-A47D9EC95E35Q28217959-1CB7A258-A1DC-4F34-B6F3-E00B4A599122Q28282330-0FD1CD77-2692-4DDC-A4F3-72B4277102E8Q28359547-0E71FD3D-B20C-47DC-B664-58915255FC52Q28390954-DC10F251-DF6F-452D-85EC-CCCD4BC3141CQ28392062-DE290808-87B5-4417-9594-F0B6F68C93A4Q28395929-19CB1058-874C-4D07-A54C-F5BA490DFC46Q28469137-0026874C-9022-4A8D-9ABE-4353A7F5352BQ28484855-7BD30BDC-E830-4873-A1D8-41BB511D098BQ28547313-27BEAEEA-3D68-46FB-8A2F-4E5E8E362C40Q28740799-9667B081-54AD-4897-ACD1-F53C271A324CQ28748169-C6CFDC4B-A7F5-4108-B5C9-B067FA2F29F8Q28752596-109EEE05-D8C6-480E-8766-9F35B6AF4A30Q30489177-0A52A937-6797-4433-921E-3B88228369BAQ31032483-89DA9B06-4635-4A53-87E0-E45AE33F4142Q31063042-0E4A4968-2491-4098-AE32-FB47EA68D25CQ33236625-D04606F4-D5FC-45A5-BA05-1CE3FC9C60EDQ33246696-70DAAFA6-BD24-4286-9695-E12C0D7BCC29Q33279360-CD6FC434-EACE-434B-9EBE-000AF786DE51Q33293231-D1EF072B-A910-4522-B5A1-E1FB92AFC9D9Q33307801-CE95D2CD-157D-4A35-8E69-9CA15DDB49C2Q33312874-B65B3C55-FCB2-410A-A8BD-22731225C13D
P2860
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
description
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@en
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@nl
type
label
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@en
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@nl
prefLabel
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@en
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@nl
P1476
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
@en
P304
P356
10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600
P407
P433
supplement_3
P577
2000-04-01T00:00:00Z